S&P 500   3,637.77 (+0.22%)
DOW   29,918.40 (+0.15%)
QQQ   298.85 (+0.87%)
AAPL   116.46 (+0.37%)
MSFT   215.40 (+0.72%)
FB   276.82 (+0.45%)
GOOGL   1,781.25 (+0.97%)
AMZN   3,198.66 (+0.43%)
TSLA   587.86 (+2.41%)
NVDA   530.22 (+0.16%)
BABA   276.56 (-0.42%)
CGC   28.46 (+5.92%)
GE   10.36 (-1.33%)
MU   64.11 (+1.07%)
AMD   86.88 (+0.20%)
T   28.97 (-0.07%)
NIO   53.85 (+0.30%)
F   9.08 (+0.00%)
ACB   9.97 (+14.47%)
NFLX   489.56 (+0.94%)
GILD   59.86 (+0.61%)
BA   216.43 (-0.54%)
DIS   146.80 (-1.54%)
S&P 500   3,637.77 (+0.22%)
DOW   29,918.40 (+0.15%)
QQQ   298.85 (+0.87%)
AAPL   116.46 (+0.37%)
MSFT   215.40 (+0.72%)
FB   276.82 (+0.45%)
GOOGL   1,781.25 (+0.97%)
AMZN   3,198.66 (+0.43%)
TSLA   587.86 (+2.41%)
NVDA   530.22 (+0.16%)
BABA   276.56 (-0.42%)
CGC   28.46 (+5.92%)
GE   10.36 (-1.33%)
MU   64.11 (+1.07%)
AMD   86.88 (+0.20%)
T   28.97 (-0.07%)
NIO   53.85 (+0.30%)
F   9.08 (+0.00%)
ACB   9.97 (+14.47%)
NFLX   489.56 (+0.94%)
GILD   59.86 (+0.61%)
BA   216.43 (-0.54%)
DIS   146.80 (-1.54%)
S&P 500   3,637.77 (+0.22%)
DOW   29,918.40 (+0.15%)
QQQ   298.85 (+0.87%)
AAPL   116.46 (+0.37%)
MSFT   215.40 (+0.72%)
FB   276.82 (+0.45%)
GOOGL   1,781.25 (+0.97%)
AMZN   3,198.66 (+0.43%)
TSLA   587.86 (+2.41%)
NVDA   530.22 (+0.16%)
BABA   276.56 (-0.42%)
CGC   28.46 (+5.92%)
GE   10.36 (-1.33%)
MU   64.11 (+1.07%)
AMD   86.88 (+0.20%)
T   28.97 (-0.07%)
NIO   53.85 (+0.30%)
F   9.08 (+0.00%)
ACB   9.97 (+14.47%)
NFLX   489.56 (+0.94%)
GILD   59.86 (+0.61%)
BA   216.43 (-0.54%)
DIS   146.80 (-1.54%)
S&P 500   3,637.77 (+0.22%)
DOW   29,918.40 (+0.15%)
QQQ   298.85 (+0.87%)
AAPL   116.46 (+0.37%)
MSFT   215.40 (+0.72%)
FB   276.82 (+0.45%)
GOOGL   1,781.25 (+0.97%)
AMZN   3,198.66 (+0.43%)
TSLA   587.86 (+2.41%)
NVDA   530.22 (+0.16%)
BABA   276.56 (-0.42%)
CGC   28.46 (+5.92%)
GE   10.36 (-1.33%)
MU   64.11 (+1.07%)
AMD   86.88 (+0.20%)
T   28.97 (-0.07%)
NIO   53.85 (+0.30%)
F   9.08 (+0.00%)
ACB   9.97 (+14.47%)
NFLX   489.56 (+0.94%)
GILD   59.86 (+0.61%)
BA   216.43 (-0.54%)
DIS   146.80 (-1.54%)
Log in
TSE:PLI

ProMetic Life Sciences Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume921 shs
Average Volume8,002 shs
Market CapitalizationC$315.66 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Prometic Life Sciences Inc. operates as a biopharmaceutical company with two drug discovery platforms that focuses on unmet medical needs in the field of fibrosis and orphan diseases. Its product pipeline includes PBI-4050, an orally active lead drug candidate for fibrosis; plasminogen, a biopharmaceutical for the treatment of congenital plasminogen deficiency; and intravenous immunoglobulin, a preparation of antibodies purified from plasma donations from healthy individuals. The company was founded in 1992 and is based in Laval, Canada.
Read More
ProMetic Life Sciences logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.52 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-450-7810115
Employees487

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$39.91 million
Book ValueC$6.07 per share

Profitability

Miscellaneous

Market CapC$315.66 million
Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive PLI News and Ratings via Email

Sign-up to receive the latest news and ratings for PLI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











ProMetic Life Sciences (TSE:PLI) Frequently Asked Questions

What stocks does MarketBeat like better than ProMetic Life Sciences?

Wall Street analysts have given ProMetic Life Sciences a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but ProMetic Life Sciences wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of ProMetic Life Sciences' key competitors?

What other stocks do shareholders of ProMetic Life Sciences own?

Who are ProMetic Life Sciences' key executives?

ProMetic Life Sciences' management team includes the following people:
  • Mr. Kenneth H. Galbraith, CEO & Director (Age 56)
  • Mr. Bruce Pritchard, International COO & Interim CFO
  • Mr. Patrick Sartore, Chief Legal Officer & Corp. Sec.
  • Mr. Bruce Wendel, Chief Bus. Devel. Officer (Age 65)
  • Dr. John Moran, Chief Medical Officer (Age 73)

What is ProMetic Life Sciences' stock symbol?

ProMetic Life Sciences trades on the Toronto Stock Exchange (TSX) under the ticker symbol "PLI."

How do I buy shares of ProMetic Life Sciences?

Shares of PLI and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

How big of a company is ProMetic Life Sciences?

ProMetic Life Sciences has a market capitalization of C$0.00 and generates C$39.91 million in revenue each year. ProMetic Life Sciences employs 487 workers across the globe.

What is ProMetic Life Sciences' official website?

The official website for ProMetic Life Sciences is prometic.com.

How can I contact ProMetic Life Sciences?

ProMetic Life Sciences' mailing address is 440 Armand-Frappier Blvd Suite 300, LAVAL, QC H7V 4B4, Canada. The company can be reached via phone at +1-450-7810115.

This page was last updated on 11/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.